Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−1.27EUR
−4.53 MEUR
3.55 M
About Protagenic Therapeutics, Inc.
Protagenic Therapeutics, Inc. operates as a biotechnology company. It engages in the discovery and development of therapeutics to treat stress-related disorders including post-traumatic stress disorder, depression, anxiety, and drug & alcohol addiction. The firm offers PT00114 peptide-based formulations. The company was founded by Garo H. Armen, David A. Lovejoy, and Hartoun Hartounian on February 3, 1994 and is headquartered in New York, NY.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of MBP is 1.49 EUR — it has decreased by 2.61% in the past 24 hours. Watch PROTAGENIC THERAPEUTICS INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange PROTAGENIC THERAPEUTICS INC stocks are traded under the ticker MBP.
MBP stock has risen by 19.20% compared to the previous week, the month change is a 6.43% rise, over the last year PROTAGENIC THERAPEUTICS INC has showed a 25.13% decrease.
MBP stock is 2.68% volatile and has beta coefficient of 1.35. Track PROTAGENIC THERAPEUTICS INC stock price on the chart and check out the list of the most volatile stocks — is PROTAGENIC THERAPEUTICS INC there?
Today PROTAGENIC THERAPEUTICS INC has the market capitalization of 6.85 M, it has decreased by 9.56% over the last week.
Yes, you can track PROTAGENIC THERAPEUTICS INC financials in yearly and quarterly reports right on TradingView.
PROTAGENIC THERAPEUTICS INC is going to release the next earnings report on Aug 20, 2024. Keep track of upcoming events with our Earnings Calendar.
MBP net income for the last quarter is −1.60 M EUR, while the quarter before that showed −1.52 M EUR of net income which accounts for −5.23% change. Track more PROTAGENIC THERAPEUTICS INC financial stats to get the full picture.
No, MBP doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of May 24, 2024, the company has 3.00 employees. See our rating of the largest employees — is PROTAGENIC THERAPEUTICS INC on this list?
Like other stocks, MBP shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade PROTAGENIC THERAPEUTICS INC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So PROTAGENIC THERAPEUTICS INC technincal analysis shows the buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating PROTAGENIC THERAPEUTICS INC stock shows the buy signal. See more of PROTAGENIC THERAPEUTICS INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.